Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01161862 · ClinicalTrials.gov registry record · NA
Integration of Continuous Glucose Monitoring Into a BiHormonal Closed-Loop Artificial Pancreas
A NA study, sponsored by Boston University Charles River Campus.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT01161862 is a NA study that has completed, run by Boston University Charles River Campus. The registered enrollment target is 24 participants.
The verdict
NCT01161862, a NA study, has completed, sponsored by Boston University Charles River Campus.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The investigators hypothesize that our closed-loop glucose-control system can provide BG control in subjects with type 1 diabetes using the estimated BG signal from a CGM as the input signal to the controller.
Interventions
- DEVICE Bi-hormonal (insulin and glucagon) artificial pancreas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-07 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01161862
The ClinicalTrials.gov registry entry for NCT01161862 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University Charles River Campus, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bi-hormonal (insulin and glucagon) artificial pancreas is the first listed.
NCT01161862 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01161862 about?
NCT01161862 is a clinical study titled "Integration of Continuous Glucose Monitoring Into a BiHormonal Closed-Loop Artificial Pancreas". The investigators hypothesize that our closed-loop glucose-control system can provide BG control in subjects with type 1 diabetes using the estimated BG signal from a CGM as the input signal to the controller.
What is the current status of trial NCT01161862?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2010-07. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01161862?
The interventions under investigation include: Bi-hormonal (insulin and glucagon) artificial pancreas (DEVICE).
Who is sponsoring clinical trial NCT01161862?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.